{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:39:00Z","timestamp":1792787940895,"version":"4.5.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China grants","doi-asserted-by":"crossref","award":["82371034"],"award-info":[{"award-number":["82371034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Hunan Province grants","award":["2022JJ30065"],"award-info":[{"award-number":["2022JJ30065"]}]},{"name":"Beijing Physician Scientist Training Project","award":["BJPSTP-2024-06"],"award-info":[{"award-number":["BJPSTP-2024-06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04050-7","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T01:59:39Z","timestamp":1746496779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Correlation among ocular surface changes and systemic hematologic indexes and disease activity in primary Sj\u00f6gren\u2019s syndrome: a cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4357-4082","authenticated-orcid":false,"given":"Yan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4772-9416","authenticated-orcid":false,"given":"Jianing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0398-591X","authenticated-orcid":false,"given":"Wen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-0035","authenticated-orcid":false,"given":"Yuerong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8684-7629","authenticated-orcid":false,"given":"Yingyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5348-2184","authenticated-orcid":false,"given":"Huanmin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4815-619X","authenticated-orcid":false,"given":"Jing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9362-2214","authenticated-orcid":false,"given":"Ying","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"4050_CR1","doi-asserted-by":"publisher","first-page":"102364","DOI":"10.1016\/j.jaut.2019.102364","volume":"110","author":"CP Mavragani","year":"2020","unstructured":"Mavragani CP, Moutsopoulos HM. Sjogren\u2019s syndrome: old and new therapeutic targets. J Autoimmun. 2020;110:102364. https:\/\/doi.org\/10.1016\/j.jaut.2019.102364","journal-title":"J Autoimmun"},{"issue":"1suppl","key":"4050_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/0961203318801673","volume":"27","author":"SJ Bowman","year":"2018","unstructured":"Bowman SJ. Primary Sj\u00f6gren\u2019s syndrome. Lupus. 2018;27(1suppl):32\u20135. https:\/\/doi.org\/10.1177\/0961203318801673","journal-title":"Lupus"},{"issue":"1","key":"4050_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ophtha.2014.07.026","volume":"122","author":"EK Akpek","year":"2015","unstructured":"Akpek EK, Mathews P, Hahn S, Hessen M, Kim J, Grader-Beck T, et al. Ocular and systemic morbidity in a longitudinal cohort of Sj\u00f6gren\u2019s syndrome. Ophthalmology. 2015;122(1):56\u201361. https:\/\/doi.org\/10.1016\/j.ophtha.2014.07.026","journal-title":"Ophthalmology"},{"issue":"1","key":"4050_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/s1542-0124(11)70005-2","volume":"9","author":"J Murube","year":"2011","unstructured":"Murube J. Primary and secondary Sjogren-Jones Syndromes\u2014Historical evolution. Ocul Surf. 2011;9(1):13\u2013. https:\/\/doi.org\/10.1016\/s1542-0124(11)70005-2. \u20096.","journal-title":"Ocul Surf"},{"issue":"2","key":"4050_CR5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jtos.2014.12.001","volume":"13","author":"GN Foulks","year":"2015","unstructured":"Foulks GN, Forstot SL, Donshik PC, Forstot JZ, Goldstein MH, Lemp MA, et al. Clinical guidelines for management of dry eye associated with Sjogren disease. Ocul Surf. 2015;13(2):118\u201332. https:\/\/doi.org\/10.1016\/j.jtos.2014.12.001","journal-title":"Ocul Surf"},{"issue":"5","key":"4050_CR6","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/ICO.0000000000001865","volume":"38","author":"EK Akpek","year":"2019","unstructured":"Akpek EK, Bunya VY, Saldanha IJ. Sjogren\u2019s syndrome: more than just dry eye. Cornea. 2019;38(5):658\u201361. https:\/\/doi.org\/10.1097\/ICO.0000000000001865","journal-title":"Cornea"},{"issue":"4","key":"4050_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000487487","volume":"59","author":"DA Sullivan","year":"2018","unstructured":"Sullivan DA, Dana R, Sullivan RM, Krenzer KL, Sahin A, Arica B, et al. Meibomian gland dysfunction in primary and secondary Sjogren syndrome. Ophthalmic Res. 2018;59(4):193\u2013205. https:\/\/doi.org\/10.1159\/000487487","journal-title":"Ophthalmic Res"},{"issue":"12","key":"4050_CR8","doi-asserted-by":"publisher","first-page":"e048336","DOI":"10.1136\/bmjopen-2020-048336","volume":"11","author":"C Zi","year":"2021","unstructured":"Zi C, Huang Q, Ren Y, Yao H, He T, Gao Y. Meibomian gland dysfunction and primary Sj\u00f6gren\u2019s syndrome dry eye: a protocol for systematic review and meta-analysis. BMJ Open. 2021;11(12):e048336. https:\/\/doi.org\/10.1136\/bmjopen-2020-048336","journal-title":"BMJ Open"},{"issue":"2","key":"4050_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ajo.2013.04.003","volume":"156","author":"SY Lee","year":"2013","unstructured":"Lee SY, Han SJ, Nam SM, Yoon SC, Ahn JM, Kim TI, et al. Analysis of tear cytokines and clinical correlations in Sj\u00f6gren syndrome dry eye patients and non-Sj\u00f6gren syndrome dry eye patients. Am J Ophthalmol. 2013;156(2):247\u2013.e1. https:\/\/doi.org\/10.1016\/j.ajo.2013.04.003","journal-title":"Am J Ophthalmol"},{"key":"4050_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-022-02233-5","author":"G Hern\u00e1ndez-Molina","year":"2022","unstructured":"Hern\u00e1ndez-Molina G, Ruiz-Quintero N, Lima G, Hern\u00e1ndez-Ram\u00edrez D, Llorente-Ch\u00e1vez A, Saavedra-Gonz\u00e1lez V, et al. Chemokine tear levels in primary Sj\u00f6gren\u2019s syndrome and their relationship with symptoms. Int Ophthalmol. 2022. https:\/\/doi.org\/10.1007\/s10792-022-02233-5","journal-title":"Int Ophthalmol"},{"issue":"1","key":"4050_CR11","doi-asserted-by":"publisher","first-page":"7319","DOI":"10.1038\/s41598-019-43714-5","volume":"9","author":"X Chen","year":"2019","unstructured":"Chen X, Aqrawi LA, Utheim TP, Tashbayev B, Utheim \u00d8A, Reppe S, et al. Elevated cytokine levels in tears and saliva of patients with primary Sj\u00f6gren\u2019s syndrome correlate with clinical ocular and oral manifestations. Sci Rep. 2019;9(1):7319. https:\/\/doi.org\/10.1038\/s41598-019-43714-5","journal-title":"Sci Rep"},{"issue":"7\u20138","key":"4050_CR12","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1080\/09273948.2020.1767792","volume":"29","author":"B Willems","year":"2021","unstructured":"Willems B, Tong L, Minh TDT, Pham ND, Nguyen XH, Zumbansen M. Novel cytokine multiplex assay for tear fluid analysis in Sjogren\u2019s syndrome. Ocul Immunol Inflamm. 2021;29(7\u20138):1639\u201344. https:\/\/doi.org\/10.1080\/09273948.2020.1767792","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"4050_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5935\/0004-2749.20190005","volume":"82","author":"D Ozek","year":"2019","unstructured":"Ozek D, Kemer OE, Omma A. Association between systemic activity index and dry eye severity in patients with primary Sjogren syndrome. Arq Bras Oftalmol. 2019;82(1):45\u201350. https:\/\/doi.org\/10.5935\/0004-2749.20190005","journal-title":"Arq Bras Oftalmol"},{"issue":"11","key":"4050_CR14","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1097\/ico.0000000000000612","volume":"34","author":"SA Lim","year":"2015","unstructured":"Lim SA, Nam S, Kwok SK, Park SH, Chung SH. Serologic markers are associated with ocular staining score in primary Sj\u00f6gren syndrome. Cornea. 2015;34(11):1466\u201370. https:\/\/doi.org\/10.1097\/ico.0000000000000612","journal-title":"Cornea"},{"key":"4050_CR15","doi-asserted-by":"publisher","unstructured":"Lee Y, Jeon HS, Hyon JY. Correlations between clinical parameters of dry eye disease and serologic profiles in Sj\u00f6gren\u2019s syndrome. Graefe\u2019s archive for clinical and experimental ophthalmology\u2009=\u2009Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2022. https:\/\/doi.org\/10.1007\/s00417-022-05671-0","DOI":"10.1007\/s00417-022-05671-0"},{"key":"4050_CR16","doi-asserted-by":"publisher","unstructured":"Roszkowska AM, Oliverio GW, Aragona E, Inferrera L, Severo AA, Alessandrello F, et al. Ophthalmologic Manifestations of Primary Sjogren\u2019s Syndrome. Genes (Basel). 2021;12(3). https:\/\/doi.org\/10.3390\/genes12030365","DOI":"10.3390\/genes12030365"},{"issue":"2","key":"4050_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.survophthal.2019.10.004","volume":"65","author":"O Bjordal","year":"2020","unstructured":"Bjordal O, Norheim KB, R\u00f8dahl E, Jonsson R, Omdal R. Primary Sj\u00f6gren\u2019s syndrome and the eye. Surv Ophthalmol. 2020;65(2):119\u201332. https:\/\/doi.org\/10.1016\/j.survophthal.2019.10.004","journal-title":"Surv Ophthalmol"},{"key":"4050_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.03.017","author":"L Shen","year":"2017","unstructured":"Shen L, Suresh L. Autoantibodies, detection methods and panels for diagnosis of Sj\u00f6gren\u2019s syndrome. Clin Immunol. 2017;182. https:\/\/doi.org\/10.1016\/j.clim.2017.03.017.:24\u2013\u20099."},{"issue":"1","key":"4050_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12974-023-02800-2","volume":"20","author":"A Vereertbrugghen","year":"2023","unstructured":"Vereertbrugghen A, Pizzano M, Sabbione F, Keitelman IA, Shiromizu CM, Aguilar DV, et al. An ocular Th1 immune response promotes corneal nerve damage independently of the development of corneal epitheliopathy. J Neuroinflamm. 2023;20(1):120. https:\/\/doi.org\/10.1186\/s12974-023-02800-2","journal-title":"J Neuroinflamm"},{"issue":"48","key":"4050_CR20","doi-asserted-by":"publisher","first-page":"e2407648121","DOI":"10.1073\/pnas.2407648121","volume":"121","author":"A Vereertbrugghen","year":"2024","unstructured":"Vereertbrugghen A, Pizzano M, Cernutto A, Sabbione F, Keitelman IA, Aguilar DV, et al. CD4(+) T cells drive corneal nerve damage but not epitheliopathy in an acute aqueous-deficient dry eye model. Proc Natl Acad Sci USA. 2024;121(48):e2407648121. https:\/\/doi.org\/10.1073\/pnas.2407648121","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"4050_CR21","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.4049\/jimmunol.176.7.3950","volume":"176","author":"JY Niederkorn","year":"2006","unstructured":"Niederkorn JY, Stern ME, Pflugfelder SC, De Paiva CS, Corrales RM, Gao J, et al. Desiccating stress induces T cell-mediated Sj\u00f6gren\u2019s Syndrome-like lacrimal keratoconjunctivitis. J Immunol (Baltimore Md: 1950). 2006;176(7):3950\u20137. https:\/\/doi.org\/10.4049\/jimmunol.176.7.3950","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"4050_CR22","doi-asserted-by":"publisher","first-page":"602823","DOI":"10.3389\/fimmu.2020.602823","volume":"11","author":"H Zhou","year":"2020","unstructured":"Zhou H, Yang J, Tian J, Wang S. CD8(+) T lymphocytes: crucial players in Sjogren\u2019s syndrome. Front Immunol. 2020;11:602823. https:\/\/doi.org\/10.3389\/fimmu.2020.602823","journal-title":"Front Immunol"},{"key":"4050_CR23","doi-asserted-by":"publisher","first-page":"616853","DOI":"10.3389\/fimmu.2021.616853","volume":"12","author":"E Gianchecchi","year":"2021","unstructured":"Gianchecchi E, Delfino DV, Fierabracci A. Natural killer cells: potential biomarkers and therapeutic target in autoimmune diseases?? Front Immunol. 2021;12:616853. https:\/\/doi.org\/10.3389\/fimmu.2021.616853","journal-title":"Front Immunol"},{"key":"4050_CR24","doi-asserted-by":"publisher","first-page":"1468469","DOI":"10.3389\/fimmu.2024.1468469","volume":"15","author":"Q Meng","year":"2024","unstructured":"Meng Q, Ma J, Cui J, Gu Y, Shan Y. Subpopulation dynamics of T and B lymphocytes in Sj\u00f6gren\u2019s syndrome: implications for disease activity and treatment. Front Immunol. 2024;15:1468469. https:\/\/doi.org\/10.3389\/fimmu.2024.1468469","journal-title":"Front Immunol"},{"issue":"4","key":"4050_CR25","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s11357-022-00529-z","volume":"44","author":"CM Trujillo-Vargas","year":"2022","unstructured":"Trujillo-Vargas CM, Mauk KE, Hernandez H, de Souza RG, Yu Z, Galletti JG, et al. Immune phenotype of the CD4(+) T cells in the aged lymphoid organs and lacrimal glands. GeroScience. 2022;44(4):2105\u201328. https:\/\/doi.org\/10.1007\/s11357-022-00529-z","journal-title":"GeroScience"},{"issue":"5","key":"4050_CR26","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.ajpath.2024.01.015","volume":"194","author":"M Pizzano","year":"2024","unstructured":"Pizzano M, Vereertbrugghen A, Cernutto A, Sabbione F, Keitelman IA, Shiromizu CM, et al. Transient receptor potential Vanilloid-1 channels facilitate axonal degeneration of corneal sensory nerves in dry eye. Am J Pathol. 2024;194(5):810\u201327. https:\/\/doi.org\/10.1016\/j.ajpath.2024.01.015","journal-title":"Am J Pathol"},{"issue":"2","key":"4050_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/imm.13243","volume":"161","author":"M Guzm\u00e1n","year":"2020","unstructured":"Guzm\u00e1n M, Miglio M, Keitelman I, Shiromizu CM, Sabbione F, Fuentes F, et al. Transient tear hyperosmolarity disrupts the neuroimmune homeostasis of the ocular surface and facilitates dry eye onset. Immunology. 2020;161(2):148\u201361. https:\/\/doi.org\/10.1111\/imm.13243","journal-title":"Immunology"},{"issue":"4","key":"4050_CR28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41385-018-0127-z","volume":"12","author":"F Bian","year":"2019","unstructured":"Bian F, Xiao Y, Barbosa FL, de Souza RG, Hernandez H, Yu Z, et al. Age-associated antigen-presenting cell alterations promote dry-eye inducing Th1 cells. Mucosal Immunol. 2019;12(4):897\u2013908. https:\/\/doi.org\/10.1038\/s41385-018-0127-z","journal-title":"Mucosal Immunol"},{"issue":"6","key":"4050_CR29","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/ard.2010.143743","volume":"70","author":"R Seror","year":"2011","unstructured":"Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, et al. EULAR Sjogren\u2019s syndrome patient reported index (ESSPRI): development of a consensus patient index for primary Sjogren\u2019s syndrome. Ann Rheum Dis. 2011;70(6):968\u201372. https:\/\/doi.org\/10.1136\/ard.2010.143743","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4050_CR30","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/ard.2009.110619","volume":"69","author":"R Seror","year":"2010","unstructured":"Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, et al. EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome. Ann Rheum Dis. 2010;69(6):1103\u20139. https:\/\/doi.org\/10.1136\/ard.2009.110619","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4050_CR31","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/annrheumdis-2014-206008","volume":"75","author":"R Seror","year":"2016","unstructured":"Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG, et al. Defining disease activity States and clinically meaningful improvement in primary Sjogren\u2019s syndrome with EULAR primary Sjogren\u2019s syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann Rheum Dis. 2016;75(2):382\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206008","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4050_CR32","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118(5):615\u201321. https:\/\/doi.org\/10.1001\/archopht.118.5.615","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"4050_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","volume":"79","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brito-Zeron P, Bombardieri S, Bootsma H, De Vita S, Dorner T, et al. EULAR recommendations for the management of Sjogren\u2019s syndrome with topical and systemic therapies. Ann Rheum Dis. 2020;79(1):3\u201318. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216114","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4050_CR34","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334\u201365. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.003","journal-title":"Ocul Surf"},{"issue":"3","key":"4050_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ajo.2009.09.013","volume":"149","author":"JP Whitcher","year":"2010","unstructured":"Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, et al. A simplified quantitative method for assessing keratoconjunctivitis Sicca from the Sjogren\u2019s syndrome international registry. Am J Ophthalmol. 2010;149(3):405\u201315. https:\/\/doi.org\/10.1016\/j.ajo.2009.09.013","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"4050_CR36","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","volume":"22","author":"AJ Bron","year":"2003","unstructured":"Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22(7):640\u201350. https:\/\/doi.org\/10.1097\/00003226-200310000-00008","journal-title":"Cornea"},{"key":"4050_CR37","doi-asserted-by":"publisher","unstructured":"Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci. 2011;52(4):1994\u20132005. https:\/\/doi.org\/10.1167\/iovs.10-6997e","DOI":"10.1167\/iovs.10-6997e"},{"issue":"Suppl 2","key":"4050_CR38","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1097\/ICL.0000000000000435","volume":"44","author":"H Pult","year":"2018","unstructured":"Pult H, Bandlitz S. Lid-Parallel conjunctival folds and their ability to predict dry eye. Eye Contact Lens. 2018;44(Suppl 2):S113\u20139. https:\/\/doi.org\/10.1097\/ICL.0000000000000435","journal-title":"Eye Contact Lens"},{"issue":"6","key":"4050_CR39","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/s0161-6420(85)33967-2","volume":"92","author":"SCG Tseng","year":"1985","unstructured":"Tseng SCG. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology. 1985;92(6):728\u201333. https:\/\/doi.org\/10.1016\/s0161-6420(85)33967-2","journal-title":"Ophthalmology"},{"issue":"4","key":"4050_CR40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jtos.2015.05.003","volume":"13","author":"MJ Doughty","year":"2015","unstructured":"Doughty MJ. Assessment of consistency in assignment of severe (Grade 3) squamous metaplasia to human bulbar conjunctiva impression cytology cell samples. Ocul Surf. 2015;13(4):284\u201397. https:\/\/doi.org\/10.1016\/j.jtos.2015.05.003","journal-title":"Ocul Surf"},{"key":"4050_CR41","doi-asserted-by":"publisher","unstructured":"Parisis D, Chivasso C, Perret J, Soyfoo MS, Delporte C. Current State of Knowledge on Primary Sj\u00f6gren\u2019s Syndrome, an Autoimmune Exocrinopathy. J Clin Med. 2020;9(7). https:\/\/doi.org\/10.3390\/jcm9072299","DOI":"10.3390\/jcm9072299"},{"key":"4050_CR42","doi-asserted-by":"publisher","first-page":"102590","DOI":"10.1016\/j.jaut.2020.102590","volume":"117","author":"B Wang","year":"2021","unstructured":"Wang B, Chen S, Zheng Q, Li Y, Zhang X, Xuan J, et al. Early diagnosis and treatment for Sj\u00f6gren\u2019s syndrome: current challenges, redefined disease stages and future prospects. J Autoimmun. 2021;117:102590. https:\/\/doi.org\/10.1016\/j.jaut.2020.102590","journal-title":"J Autoimmun"},{"issue":"2","key":"4050_CR43","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1167\/iovs.14-13864","volume":"56","author":"KL Menzies","year":"2015","unstructured":"Menzies KL, Srinivasan S, Prokopich CL, Jones L. Infrared imaging of meibomian glands and evaluation of the lipid layer in Sj\u00f6gren\u2019s syndrome patients and Nondry eye controls. Invest Ophthalmol Vis Sci. 2015;56(2):836\u201341. https:\/\/doi.org\/10.1167\/iovs.14-13864","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"4050_CR44","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1038\/s41598-022-06191-x","volume":"12","author":"M Kim","year":"2022","unstructured":"Kim M, Chun YS, Kim KW. Different perception of dry eye symptoms between patients with and without primary Sjogren\u2019s syndrome. Sci Rep. 2022;12(1):2172. https:\/\/doi.org\/10.1038\/s41598-022-06191-x","journal-title":"Sci Rep"},{"issue":"3","key":"4050_CR45","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ajo.2015.06.004","volume":"160","author":"PM Mathews","year":"2015","unstructured":"Mathews PM, Hahn S, Hessen M, Kim J, Grader-Beck T, Birnbaum J, et al. Ocular complications of primary Sj\u00f6gren syndrome in men. Am J Ophthalmol. 2015;160(3):447\u201352.e1. https:\/\/doi.org\/10.1016\/j.ajo.2015.06.004","journal-title":"Am J Ophthalmol"},{"issue":"14","key":"4050_CR46","doi-asserted-by":"publisher","first-page":"DES71","DOI":"10.1167\/iovs.17-23750","volume":"59","author":"Y Ogawa","year":"2018","unstructured":"Ogawa Y. Sjogren\u2019s syndrome, Non-Sjogren\u2019s syndrome, and Graft-Versus-Host disease related dry eye. Invest Ophthalmol Vis Sci. 2018;59(14):DES71\u20139. https:\/\/doi.org\/10.1167\/iovs.17-23750","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"4050_CR47","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1080\/09273948.2021.1903935","volume":"29","author":"Z Tauqeer","year":"2021","unstructured":"Tauqeer Z, Bunya VY, Macchi I, Massaro-Giordano M. Ocular pathophysiology of Sj\u00f6gren\u2019s syndrome. Ocul Immunol Inflamm. 2021;29(4):796\u2013802. https:\/\/doi.org\/10.1080\/09273948.2021.1903935","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"4050_CR48","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1167\/iovs.09-4130","volume":"51","author":"SK Ward","year":"2010","unstructured":"Ward SK, Wakamatsu TH, Dogru M, Ibrahim OM, Kaido M, Ogawa Y, et al. The role of oxidative stress and inflammation in conjunctivochalasis. Invest Ophthalmol Vis Sci. 2010;51(4):1994\u20132002. https:\/\/doi.org\/10.1167\/iovs.09-4130","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"4050_CR49","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/ico.0000000000001800","volume":"38","author":"J Cardigos","year":"2019","unstructured":"Cardigos J, Barcelos F, Carvalho H, Hip\u00f3lito D, Cris\u00f3stomo S, Vaz-Patto J, et al. Tear meniscus and corneal Sub-basal nerve plexus assessment in primary Sj\u00f6gren syndrome and Sicca syndrome patients. Cornea. 2019;38(2):221\u20138. https:\/\/doi.org\/10.1097\/ico.0000000000001800","journal-title":"Cornea"},{"key":"4050_CR50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ajo.2016.09.013","volume":"172","author":"VY Bunya","year":"2016","unstructured":"Bunya VY, Bhosai SJ, Heidenreich AM, Kitagawa K, Larkin GB, Lietman TM, et al. Association of dry eye tests with extraocular signs among 3514 participants in the Sj\u00f6gren\u2019s syndrome international registry. Am J Ophthalmol. 2016;172:87\u201393. https:\/\/doi.org\/10.1016\/j.ajo.2016.09.013","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"4050_CR51","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12886-021-01871-0","volume":"21","author":"JE Kim","year":"2021","unstructured":"Kim JE, Kim NR, Chin HS, Seo KY, Kim TI, Jung JW. Factors associated with ocular surface epithelial damage in patients with primary Sj\u00f6gren\u2019s syndrome. BMC Ophthalmol. 2021;21(1):114. https:\/\/doi.org\/10.1186\/s12886-021-01871-0","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"4050_CR52","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s10067-019-04438-z","volume":"38","author":"M Ma\u015bli\u0144ska","year":"2019","unstructured":"Ma\u015bli\u0144ska M, Ma\u0144czak M, Kwiatkowska B. Usefulness of rheumatoid factor as an immunological and prognostic marker in PSS patients. Clin Rheumatol. 2019;38(5):1301\u20137. https:\/\/doi.org\/10.1007\/s10067-019-04438-z","journal-title":"Clin Rheumatol"},{"issue":"11","key":"4050_CR53","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1097\/ico.0000000000001714","volume":"37","author":"VY Bunya","year":"2018","unstructured":"Bunya VY, Ying GS, Maguire MG, Kuklinski E, Lin MC, Peskin E, et al. Prevalence of novel candidate Sjogren syndrome autoantibodies in the dry eye assessment and management (DREAM) study. Cornea. 2018;37(11):1425\u201330. https:\/\/doi.org\/10.1097\/ico.0000000000001714","journal-title":"Cornea"},{"issue":"4","key":"4050_CR54","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.survophthal.2017.10.010","volume":"63","author":"A Marmalidou","year":"2018","unstructured":"Marmalidou A, Kheirkhah A, Dana R. Conjunctivochalasis: a systematic review. Surv Ophthalmol. 2018;63(4):554\u2013. https:\/\/doi.org\/10.1016\/j.survophthal.2017.10.010. \u200964.","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"4050_CR55","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/s0039-6257(98)00037-x","volume":"43","author":"D Meller","year":"1998","unstructured":"Meller D, Tseng SC. Conjunctivochalasis: literature review and possible pathophysiology. Surv Ophthalmol. 1998;43(3):225\u201332. https:\/\/doi.org\/10.1016\/s0039-6257(98)00037-x","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"4050_CR56","doi-asserted-by":"publisher","first-page":"e001033","DOI":"10.1136\/rmdopen-2019-001033","volume":"5","author":"S Abbara","year":"2019","unstructured":"Abbara S, Seror R, Henry J, Chretien P, Gleizes A, Hacein-Bey-Abina S, et al. Anti-RNP positivity in primary Sjogren\u2019s syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement. RMD Open. 2019;5(2):e001033. https:\/\/doi.org\/10.1136\/rmdopen-2019-001033","journal-title":"RMD Open"},{"issue":"3","key":"4050_CR57","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaut.2012.05.014","volume":"39","author":"D Cornec","year":"2012","unstructured":"Cornec D, Devauchelle-Pensec V, Tobon GJ, Pers JO, Jousse-Joulin S, Saraux A. B cells in Sjogren\u2019s syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun. 2012;39(3):161\u20137. https:\/\/doi.org\/10.1016\/j.jaut.2012.05.014","journal-title":"J Autoimmun"},{"issue":"8","key":"4050_CR58","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/icb.2017.38","volume":"95","author":"JY Barr","year":"2017","unstructured":"Barr JY, Wang X, Meyerholz DK, Lieberman SM. CD8 T cells contribute to lacrimal gland pathology in the Nonobese diabetic mouse model of Sjogren syndrome. Immunol Cell Biol. 2017;95(8):684\u201394. https:\/\/doi.org\/10.1038\/icb.2017.38","journal-title":"Immunol Cell Biol"},{"issue":"4","key":"4050_CR59","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s10067-021-06011-z","volume":"41","author":"X Zhou","year":"2022","unstructured":"Zhou X, Li Q, Li Y, Fu J, Sun F, Li Y, et al. Diminished natural killer T-like cells correlates with aggravated primary Sjogren\u2019s syndrome. Clin Rheumatol. 2022;41(4):1163\u20138. https:\/\/doi.org\/10.1007\/s10067-021-06011-z","journal-title":"Clin Rheumatol"},{"key":"4050_CR60","doi-asserted-by":"publisher","first-page":"6658324","DOI":"10.1155\/2021\/6658324","volume":"2021","author":"S Wang","year":"2021","unstructured":"Wang S, Shen H, Bai B, Wu J, Wang J. Increased CD4(+)CD8(+) Double-Positive T cell in patients with primary Sjogren\u2019s syndrome correlated with disease activity. J Immunol Res. 2021;2021:6658324. https:\/\/doi.org\/10.1155\/2021\/6658324","journal-title":"J Immunol Res"},{"issue":"2","key":"4050_CR61","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/rheumatology\/keaa105","volume":"60","author":"J Fessler","year":"2021","unstructured":"Fessler J, Fasching P, Raicht A, Hammerl S, Weber J, Lackner A, et al. Lymphopenia in primary Sj\u00f6gren\u2019s syndrome is associated with premature aging of Na\u00efve CD4\u2009+\u2009T cells. Rheumatology (Oxford). 2021;60(2):588\u201397. https:\/\/doi.org\/10.1093\/rheumatology\/keaa105","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"4050_CR62","doi-asserted-by":"publisher","first-page":"e1244","DOI":"10.1002\/iid3.1244","volume":"12","author":"P Zhao","year":"2024","unstructured":"Zhao P, Yang Y, Song S, Cheng W, Peng C, Chang X, et al. The proportion of CD161 on CD56(+) NK cells in peripheral circulation associates with clinical features and disease activity of primary Sj\u00f6gren\u2019s syndrome. Immun Inflamm Dis. 2024;12(4):e1244. https:\/\/doi.org\/10.1002\/iid3.1244","journal-title":"Immun Inflamm Dis"},{"issue":"5","key":"4050_CR63","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s10067-022-06491-7","volume":"42","author":"H Li","year":"2023","unstructured":"Li H, Zhou Y, Wang P, Wang Y, Feng Y, Zhang Y, et al. Alterations of CD8(+) T cells in the blood and salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome. Clin Rheumatol. 2023;42(5):1327\u201338. https:\/\/doi.org\/10.1007\/s10067-022-06491-7","journal-title":"Clin Rheumatol"},{"key":"4050_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-024-07295-7","author":"Y Han","year":"2025","unstructured":"Han Y, Wang R, Sun F, Feng R, Li H, Ning Y, et al. Anti-SSA\/SSB antibody double-negative Sj\u00f6gren\u2019s disease patients: a comprehensive clinical study and immune profile. Clin Rheumatol. 2025. https:\/\/doi.org\/10.1007\/s10067-024-07295-7","journal-title":"Clin Rheumatol"},{"key":"4050_CR65","doi-asserted-by":"publisher","unstructured":"Kudryavtsev I, Benevolenskaya S, Serebriakova M, Grigor\u2019yeva I, Kuvardin E, Rubinstein A, et al. Circulating CD8\u2009+\u2009T cell subsets in primary Sj\u00f6gren\u2019s syndrome. Biomedicines. 2023;11(10). https:\/\/doi.org\/10.3390\/biomedicines11102778","DOI":"10.3390\/biomedicines11102778"},{"issue":"6","key":"4050_CR66","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1189\/jlb.1110611","volume":"89","author":"Y Chen","year":"2011","unstructured":"Chen Y, Chauhan SK, Saban DR, Sadrai Z, Okanobo A, Dana R. Interferon-\u03b3-secreting NK cells promote induction of dry eye disease. J Leukoc Biol. 2011;89(6):965\u201372. https:\/\/doi.org\/10.1189\/jlb.1110611","journal-title":"J Leukoc Biol"},{"key":"4050_CR67","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.exer.2013.07.015","volume":"117","author":"N Blaul","year":"2013","unstructured":"von Thun Und Hohenstein-, Blaul N, Funke S, Grus FH. Tears as a source of biomarkers for ocular and systemic diseases. Exp Eye Res. 2013;117:126\u201337. https:\/\/doi.org\/10.1016\/j.exer.2013.07.015","journal-title":"Exp Eye Res"},{"key":"4050_CR68","doi-asserted-by":"publisher","first-page":"155640","DOI":"10.1016\/j.cyto.2021.155640","volume":"146","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S, Shahir M, Taheri M, Salimi A. A review on the role of chemokines in the pathogenesis of systemic lupus erythematosus. Cytokine. 2021;146:155640. https:\/\/doi.org\/10.1016\/j.cyto.2021.155640","journal-title":"Cytokine"},{"key":"4050_CR69","doi-asserted-by":"publisher","unstructured":"Fallahi P, Ferrari SM, Ragusa F, Ruffilli I, Elia G, Paparo SR, et al. Th1 chemokines in autoimmune endocrine disorders. J Clin Endocrinol Metab. 2020;105(4). https:\/\/doi.org\/10.1210\/clinem\/dgz289","DOI":"10.1210\/clinem\/dgz289"},{"issue":"4","key":"4050_CR70","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.immuni.2019.03.022","volume":"50","author":"M Dougan","year":"2019","unstructured":"Dougan M, Dranoff G, Dougan SK, GM-CSF. IL-3, and IL-5 family of cytokines: regulators of inflammation. Immunity. 2019;50(4):796\u2013811. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.022","journal-title":"Immunity"},{"key":"4050_CR71","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cytogfr.2018.12.001","volume":"45","author":"YM Mao","year":"2019","unstructured":"Mao YM, Zhao CN, Leng J, Leng RX, Ye DQ, Zheng SG, et al. Interleukin-13: A promising therapeutic target for autoimmune disease. Cytokine Growth Factor Rev. 2019;45:9\u201323. https:\/\/doi.org\/10.1016\/j.cytogfr.2018.12.001","journal-title":"Cytokine Growth Factor Rev"},{"key":"4050_CR72","doi-asserted-by":"publisher","first-page":"107823","DOI":"10.1016\/j.intimp.2021.107823","volume":"97","author":"M Arabpour","year":"2021","unstructured":"Arabpour M, Saghazadeh A, Rezaei N, Anti-inflammatory. M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes. Int Immunopharmacol. 2021;97:107823. https:\/\/doi.org\/10.1016\/j.intimp.2021.107823","journal-title":"Int Immunopharmacol"},{"key":"4050_CR73","doi-asserted-by":"publisher","first-page":"102689","DOI":"10.1016\/j.jaut.2021.102689","volume":"122","author":"HM Ren","year":"2021","unstructured":"Ren HM, Lukacher AE, Rahman ZSM, Olsen NJ. New developments implicating IL-21 in autoimmune disease. J Autoimmun. 2021;122:102689. https:\/\/doi.org\/10.1016\/j.jaut.2021.102689","journal-title":"J Autoimmun"},{"key":"4050_CR74","doi-asserted-by":"publisher","unstructured":"Ogawa Y, Shimizu E, Tsubota K. Interferons and Dry Eye in Sjogren\u2019s Syndrome. Int J Mol Sci. 2018;19(11). https:\/\/doi.org\/10.3390\/ijms19113548","DOI":"10.3390\/ijms19113548"},{"issue":"3","key":"4050_CR75","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1046\/j.1365-2249.2002.01869.x","volume":"128","author":"DI Mitsias","year":"2002","unstructured":"Mitsias DI, Tzioufas AG, Veiopoulou C, Zintzaras E, Tassios IK, Kogopoulou O, et al. The Th1\/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren\u2019s syndrome. Clin Exp Immunol. 2002;128(3):562\u20138. https:\/\/doi.org\/10.1046\/j.1365-2249.2002.01869.x","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"4050_CR76","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.autrev.2018.05.005","volume":"17","author":"K Psianou","year":"2018","unstructured":"Psianou K, Panagoulias I, Papanastasiou AD, de Lastic AL, Rodi M, Spantidea PI, et al. Clinical and immunological parameters of Sj\u00f6gren\u2019s syndrome. Autoimmun Rev. 2018;17(10):1053\u201364. https:\/\/doi.org\/10.1016\/j.autrev.2018.05.005","journal-title":"Autoimmun Rev"},{"issue":"1","key":"4050_CR77","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13075-022-02811-z","volume":"24","author":"L Shi","year":"2022","unstructured":"Shi L, Wang J, Guo HX, Han XL, Tang YP, Liu GY. Circulating Th2 cell reduction and Th1\/Th2 imbalance are correlated with primary Sjogren\u2019s syndrome-associated interstitial lung disease. Arthritis Res Therapy. 2022;24(1):121. https:\/\/doi.org\/10.1186\/s13075-022-02811-z","journal-title":"Arthritis Res Therapy"},{"issue":"6","key":"4050_CR78","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/ico.0000000000001916","volume":"38","author":"S Yang","year":"2019","unstructured":"Yang S, Lee HJ, Kim DY, Shin S, Barabino S, Chung SH. The use of conjunctival staining to measure ocular surface inflammation in patients with dry eye. Cornea. 2019;38(6):698\u2013705. https:\/\/doi.org\/10.1097\/ico.0000000000001916","journal-title":"Cornea"},{"issue":"3","key":"4050_CR79","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/ico.0000000000000363","volume":"34","author":"SA Lim","year":"2015","unstructured":"Lim SA, Nam DH, Lee JH, Kwok SK, Park SH, Chung SH. Association of IL-21 cytokine with severity of primary Sj\u00f6gren syndrome dry eye. Cornea. 2015;34(3):248\u201352. https:\/\/doi.org\/10.1097\/ico.0000000000000363","journal-title":"Cornea"},{"issue":"9","key":"4050_CR80","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425\u201340. https:\/\/doi.org\/10.1002\/jcp.26429","journal-title":"J Cell Physiol"},{"issue":"49","key":"4050_CR81","doi-asserted-by":"publisher","first-page":"e40669","DOI":"10.1097\/md.0000000000040669","volume":"103","author":"J Li","year":"2024","unstructured":"Li J, Liu Y, Liu Z, Li X. Tear cytokine levels in Sjogren\u2019s syndrome-related dry eye disease compared with non-Sjogren\u2019s syndrome-related dry eye disease patients: A meta-analysis. Medicine. 2024;103(49):e40669. https:\/\/doi.org\/10.1097\/md.0000000000040669","journal-title":"Medicine"},{"key":"4050_CR82","doi-asserted-by":"publisher","unstructured":"D\u2019Souza S, Vaidya T, Nair AP, Shetty R, Kumar NR, Bisht A, et al. Altered ocular surface health status and tear film immune profile due to prolonged daily mask wear in health care workers. Biomedicines. 2022;10(5). https:\/\/doi.org\/10.3390\/biomedicines10051160","DOI":"10.3390\/biomedicines10051160"},{"issue":"2","key":"4050_CR83","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1167\/iovs.15-18615","volume":"57","author":"L Cocho","year":"2016","unstructured":"Cocho L, Fern\u00e1ndez I, Calonge M, Mart\u00ednez V, Gonz\u00e1lez-Garc\u00eda MJ, Caballero D, et al. Biomarkers in ocular chronic graft versus host disease: tear Cytokine- and Chemokine-Based predictive model. Invest Ophthalmol Vis Sci. 2016;57(2):746\u201358. https:\/\/doi.org\/10.1167\/iovs.15-18615","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"4050_CR84","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1167\/iovs.16-20789","volume":"58","author":"TH Dohlman","year":"2017","unstructured":"Dohlman TH, Ding J, Dana R, Chauhan SK. T cell-Derived Granulocyte-Macrophage Colony-Stimulating factor contributes to dry eye disease pathogenesis by promoting CD11b\u2009+\u2009Myeloid cell maturation and migration. Invest Ophthalmol Vis Sci. 2017;58(2):1330\u20136. https:\/\/doi.org\/10.1167\/iovs.16-20789","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"4050_CR85","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/art.42859","volume":"76","author":"Y Gan","year":"2024","unstructured":"Gan Y, Zhou H, Guo Y, Huang B, Liu H, Wang Z, et al. A GITRL-mTORC1-GM-CSF positive loop promotes pathogenic Th17 response in primary Sj\u00f6gren syndrome. Arthritis Rheumatol. 2024;76(9):1419\u201330. https:\/\/doi.org\/10.1002\/art.42859","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"4050_CR86","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.4049\/jimmunol.1602144","volume":"199","author":"Y Chen","year":"2017","unstructured":"Chen Y, Chauhan SK, Shao C, Omoto M, Inomata T, Dana R. IFN-\u03b3-Expressing Th17 cells are required for development of severe ocular surface autoimmunity. J Immunol (Baltimore Md: 1950). 2017;199(3):1163\u20139. https:\/\/doi.org\/10.4049\/jimmunol.1602144","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"4050_CR87","doi-asserted-by":"publisher","unstructured":"Ushio A, Arakaki R, Eguchi H, Hotta F, Yamada A, Kudo Y, et al. Pathological Analysis of Ocular Lesions in a Murine Model of Sj\u00f6gren\u2019s Syndrome. Int J Mol Sci. 2017;18(6). https:\/\/doi.org\/10.3390\/ijms18061209","DOI":"10.3390\/ijms18061209"},{"key":"4050_CR88","doi-asserted-by":"publisher","first-page":"109470","DOI":"10.1016\/j.exer.2023.109470","volume":"231","author":"JY Qu","year":"2023","unstructured":"Qu JY, Xie HT, Xiao YT, Zhang YY, Hu ZX, Wang JS, et al. The Inhibition of p38 MAPK blocked inflammation to restore the functions of rat meibomian gland epithelial cells. Exp Eye Res. 2023;231:109470. https:\/\/doi.org\/10.1016\/j.exer.2023.109470","journal-title":"Exp Eye Res"},{"issue":"5","key":"4050_CR89","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/iovs.63.5.6","volume":"63","author":"R Liu","year":"2022","unstructured":"Liu R, Li J, Xu Y, Chen Z, Ye H, Tang J, et al. Melatonin attenuates LPS-Induced Proinflammatory cytokine response and lipogenesis in human meibomian gland epithelial cells via MAPK\/NF-\u03baB pathway. Invest Ophthalmol Vis Sci. 2022;63(5):6. https:\/\/doi.org\/10.1167\/iovs.63.5.6","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4050_CR90","doi-asserted-by":"publisher","first-page":"673658","DOI":"10.3389\/fimmu.2021.673658","volume":"12","author":"Y Liang","year":"2021","unstructured":"Liang Y, Xian Z, Fu D, Liu S, Yao Y, Jin Y, et al. IL-14\u03b1 as a putative biomarker for stratification of dry eye in primary Sj\u00f6gren\u2019s syndrome. Front Immunol. 2021;12:673658. https:\/\/doi.org\/10.3389\/fimmu.2021.673658","journal-title":"Front Immunol"},{"key":"4050_CR91","doi-asserted-by":"publisher","first-page":"106878","DOI":"10.1016\/j.intimp.2020.106878","volume":"88","author":"C Chen","year":"2020","unstructured":"Chen C, Liang Y, Zhang Z, Zhang Z, Yang Z. Relationships between increased Circulating YKL-40, IL-6 and TNF-\u03b1 levels and phenotypes and disease activity of primary Sj\u00f6gren\u2019s syndrome. Int Immunopharmacol. 2020;88:106878. https:\/\/doi.org\/10.1016\/j.intimp.2020.106878","journal-title":"Int Immunopharmacol"},{"key":"4050_CR92","doi-asserted-by":"publisher","first-page":"109191","DOI":"10.1016\/j.exer.2022.109191","volume":"222","author":"A Vereertbrugghen","year":"2022","unstructured":"Vereertbrugghen A, Galletti JG. Corneal nerves and their role in dry eye pathophysiology. Exp Eye Res. 2022;222:109191. https:\/\/doi.org\/10.1016\/j.exer.2022.109191","journal-title":"Exp Eye Res"},{"key":"4050_CR93","doi-asserted-by":"publisher","unstructured":"Guerrero-Moreno A, Liang H, Moreau N, Luzu J, Rabut G, Melik Parsadaniantz S, et al. Corneal nerve abnormalities in painful dry eye disease patients. Biomedicines. 2021;9(10). https:\/\/doi.org\/10.3390\/biomedicines9101424","DOI":"10.3390\/biomedicines9101424"},{"key":"4050_CR94","doi-asserted-by":"publisher","first-page":"610342","DOI":"10.3389\/fncel.2020.610342","volume":"14","author":"A Guerrero-Moreno","year":"2020","unstructured":"Guerrero-Moreno A, Baudouin C, Melik Parsadaniantz S, R\u00e9aux-Le Goazigo A. Morphological and functional changes of corneal nerves and their contribution to peripheral and central sensory abnormalities. Front Cell Neurosci. 2020;14:610342. https:\/\/doi.org\/10.3389\/fncel.2020.610342","journal-title":"Front Cell Neurosci"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04050-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04050-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04050-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T01:59:40Z","timestamp":1746496780000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-04050-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4050"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04050-7","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.clim.2017.03.017","asserted-by":"subject"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All subjects participated in the program voluntarily and signed informed consent forms. The study obtained written informed consent from all enrolled patients, approved by the Ethics Committee of The Second Xiangya Hospital of Central South University (Ethics code, LYF2021028). This study strictly followed the Helsinki declaration, which was implemented to in ensuring the rights and safety of the subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript before submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"270"}}